Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00ULY
|
|||
| Former ID |
DNCL001829
|
|||
| Drug Name |
KAI-9803/ BMS-875944
|
|||
| Drug Type |
Combination drug
|
|||
| Indication | Reperfusion injury [ICD-11: ND56.Z; ICD-9: 410] | Phase 2 | [1] | |
| Company |
Bristol-Myers Squibb; KAI Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Canonical SMILES |
failed
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Bristol-Myers Squibb. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.